Steve Damment
Gründer bei Aluztura Bio Ltd.
Aktive Positionen von Steve Damment
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aluztura Bio Ltd. | Gründer | 01.01.2014 | - |
Corporate Officer/Principal | 01.01.2014 | - |
Karriereverlauf von Steve Damment
Ehemalige bekannte Positionen von Steve Damment
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIODEXA PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2018 | 30.09.2021 |
Corporate Officer/Principal | 01.05.2015 | 01.06.2018 | |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01.01.2000 | 01.12.2013 |
GSK PLC | Corporate Officer/Principal | 01.07.1982 | 01.12.1999 |
Ausbildung von Steve Damment
The University of Liverpool | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BIODEXA PHARMACEUTICALS PLC | Health Technology |
GSK PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aluztura Bio Ltd. |
- Börse
- Insiders
- Steve Damment
- Erfahrung